Медицинская библиотека · The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022

Clinical standards for the dosing and management of TB drugs.

Alffenaar J W C, Stocker S L, Forsman L Davies, Garcia-Prats A, Heysell S K, Aarnoutse R E, Akkerman O W, Aleksa A, van Altena R, de Oñata W Arrazola, Bhavani P K, Van't Boveneind-Vrubleuskaya N, Carvalho A C C, Centis R, Chakaya J M, Cirillo D M, Cho J G, D Ambrosio L, Dalcolmo M P, Denti P, Dheda K, Fox G J, Hesseling A C, Kim H Y, Köser C U, Marais B J, Margineanu I, Märtson A G, Torrico M Munoz, Nataprawira H M, Ong C W M, Otto-Knapp R, Peloquin C A, Silva D R, Ruslami R, Santoso P, Savic R M, Singla R, Svensson E M, Skrahina A, van Soolingen D, Srivastava S, Tadolini M, Tiberi S, Thomas T A, Udwadia Z F, Vu D H, Zhang W, Mpagama S G, Schön T, Migliori G B

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Optimal drug dosing is important to ensure adequate response to treatment, prevent development of drug resistance and reduce drug toxicity. The aim of these clinical standards is to provide guidance on 'best practice´ for dosing and management of TB drugs.

METHODS

A panel of 57 global experts in the fields of microbiology, pharmacology and TB care were identified; 51 participated in a Delphi process. A 5-point Likert scale was used to score draft standards. The final document represents the broad consensus and was approved by all participants.

RESULTS

Six clinical standards were defined: Standard 1, defining the most appropriate initial dose for TB treatment; Standard 2, identifying patients who may be at risk of sub-optimal drug exposure; Standard 3, identifying patients at risk of developing drug-related toxicity and how best to manage this risk; Standard 4, identifying patients who can benefit from therapeutic drug monitoring (TDM); Standard 5, highlighting education and counselling that should be provided to people initiating TB treatment; and Standard 6, providing essential education for healthcare professionals. In addition, consensus research priorities were identified.

CONCLUSION

This is the first consensus-based Clinical Standards for the dosing and management of TB drugs to guide clinicians and programme managers in planning and implementation of locally appropriate measures for optimal person-centred treatment to improve patient care.

Для цитирования: Alffenaar J W C, Stocker S L, Forsman L Davies, Garcia-Prats A, Heysell S K, Aarnoutse R E, Akkerman O W, Aleksa A, van Altena R, de Oñata W Arrazola, Bhavani P K, Van't Boveneind-Vrubleuskaya N, Carvalho A C C, Centis R, Chakaya J M, Cirillo D M, Cho J G, D Ambrosio L, Dalcolmo M P, Denti P, Dheda K, Fox G J, Hesseling A C, Kim H Y, Köser C U, Marais B J, Margineanu I, Märtson A G, Torrico M Munoz, Nataprawira H M, Ong C W M, Otto-Knapp R, Peloquin C A, Silva D R, Ruslami R, Santoso P, Savic R M, Singla R, Svensson E M, Skrahina A, van Soolingen D, Srivastava S, Tadolini M, Tiberi S, Thomas T A, Udwadia Z F, Vu D H, Zhang W, Mpagama S G, Schön T, Migliori G B. Clinical standards for the dosing and management of TB drugs.. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2022. DOI: 10.5588/ijtld.22.0188.

Предметные рубрики MeSH

Humans Drug Monitoring Patient Care Reference Standards Tuberculosis Antitubercular Agents

Подготовка и перевод публикации

Обработка статьи · этапы, ошибки и управление

Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.